Clinical

The FDA's meta-analyses, following results of the DAPT trial in 2014, have found no association between treatment with the blood thinner clopidogrel (Plavix) and increased incidence of, or death due to, cancer.

A blood test that can detect mutations in the androgen receptor can predict response to abiraterone in prostate cancer.

New research, published in JAMA Oncology, presents evidence of how the use of disease-specific hashtags on Twitter can help those with common interests collectively share information.

Published in the journal Cancer, the study evaluated the short-term and long-term costs of treating patients with low-risk prostate cancer across the entire care spectrum.

According to a study published in The International Journal of Cancer, tubal ligation can reduce the risk of serous, endometrioid, and clear cell ovarian carcinoma.

A new research study published in the Journal of Dermatology has found that propranolol, a commonly used antihypertensive agent, could substantially reduce proliferation of angiosarcoma.

Fifty organizations, including the American Society of Clinical Oncology, have expressed their confidence in Robert Califf, MD, to lead the FDA.

After melanoma and non-small cell lung cancer, the FDA has granted Breakthrough Therapy status to pembrolizumab in advanced colorectal cancer patients with mismatched repair deficiency.

With the expansion, UnitedHealthcare will bring 5 more oncology practices on board to participate in its bundled program, which will grow the program to 650 oncologists across 7 states.

At the Payer Exchange Summit on Oncology Payment Reform, hosted by the Community Oncology Alliance, Daniel McKellar, MD, who chairs the Commission on Cancer, insisted on meaningful feedback from the community to ensure adequate transformation of practices into a medical home.

Olaparib, a PARP inhibitor approved for treating BRCA1/2-mutated ovarian cancer, has been found effective in treating men with metastatic, castrate-resistant prostate cancer.

What we're reading, October 29, 2015: Pfizer and Allergan in talks to merge; the House passes a budget deal with implications for Medicare beneficiaries; and autism in children is being overdiagnosed.

The drug significantly delayed recurrence of the cancer in patients treated post surgery.

What we're reading, October 28, 2015: Ben Carson plans to replace the Affordable Care Act, Medicaid, and Medicare; a homeless shelter utilizes telemedicine to alleviate emergency department visits; and researchers uncover gender gap in post-heart attack treatment.

Payer—provider teams presented updates on their cost-saving pilot projects and looked to the future of these models in oncology care.

Twenty-four states have received grants to improve the behavioral health of their citizens by providing community-based mental and substance use disorder treatment.